Approval · Notice of Compliance 9166 · 2007
PANTO-BYK: Notice of Compliance 9166
Issued November 13, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9166
- Date
- November 13, 2007
- Company
- Nycomed GmbhKonstanz, Saone Et Loire, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- H+, K+-atpase inhibitor
Products in this notice
Medicinal ingredients
- PANTOPRAZOLE SODIUM 20 MG per TAB
- PANTOPRAZOLE SODIUM 40 MG per TAB